EMA says sym­bol­ic good­bye to Lon­don HQ as it sets up shop in Am­s­ter­dam

Eu­rope’s med­i­cines reg­u­la­tor, hav­ing been based in Lon­don since 1995, is gear­ing up for its move to Am­s­ter­dam as West­min­ster’s un­cer­tain­ty re­gard­ing Brex­it shows no signs of abat­ing and drug­mak­ers is­sue warn­ings about the dis­rup­tion to drug sup­plies.

The de­ci­sion to move the Eu­ro­pean drug watch­dog was trig­gered by Britain’s 2016 de­ci­sion to leave the EU. In No­vem­ber 2017, Am­s­ter­dam was cho­sen as the EMA’s new home by EU mem­ber states, which bode well for staff who re­port­ed­ly in a sur­vey put the city at the top of the list of places they would fol­low the agency to.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER